BioSpace News Archive

SWK Holdings Expects to Report Adjusted Earnings for Fourth Quarter and Year End 2019 of $4.3 to $4.7 million and $21.0 to $21.4 million, respectively

Endocanna Health, Inc. (“Endocanna” or “the Company”), a research and development biotechnology company specializing in endocannabinoid DNA testing and precision cannabinoid formulations, announced the formalization of a Scientific Board (“Science Board” or the “Board”) to drive investment in more clinical trials and research.

Align Technology, Inc. (NASDAQ: ALGN) today announced that the Align Foundation, the Company’s donor-advised fund through Fidelity Charitable, has pledged to donate US$1 million to support COVID-19 relief efforts globally.

The oral medication for Infantile spasms (IS) is in phase 2 clinical trials in Korea and the US, and the IV medication for Status epilepticus (SE) is in phase 1 clinical trials in the US. The company has established new pipelines, including Alzheimer’s Disease, and is set to embark on clinical trials (phase 2) by expanding R&D through an IPO [26-March-2020] SUWON, S

The U.S. Department of Health and Human Services, American Society of Nephrology and National Kidney Foundation announced that 25 innovators have been selected as winners in two categories of the first-ever KidneyX: Patient Innovator Challenge, funded by NKF.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), announced today that the Company’s CEO Dr. Stuart Titus was featured in global financial news outlet Reuters discussing the impact of COVID-19 on the cannabis industry.

Micro Video Instruments Inc. (MVI) and Morrell Instrument Company will continue as authorized Nikon dealers for Clinical, Educational, Industrial and Materials markets [26-March-2020] MELVILLE, N.Y. , March 26, 2020 /PRNewswire/ -- Nikon Instruments Inc., innovator of advanced microscope systems, today announced that it will assume direct representation for all Resear

Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology today reports its 2019 financial results and provides a business update.

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced two abstracts focused on implantable neuromodulation technology for patients with heart failure will be shared at this year’s American College of Cardiology and World Congress of Cardiology Virtual meeting (ACC.20/WCC) . In lieu of traditional in-person presentations, ACC.20/WCC will share all abstracts and posters accep

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today provided an update on certain impacts of COVID-19 on its business and the actions it is taking to mitigate the spread of this virus and help protect the safety and well-being of its employees, healthcare providers, patients and broader communities. “In the face of the COVID-19 pandemic, we are taking important steps in an effort to help